featured
Efficacy of Olaparib ± Durvalumab as a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Patients With Advanced TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase II DORA Study of Olaparib with or without Durvalumab as a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Advanced Triple-Negative Breast Cancer
Clin. Cancer Res 2024 Jan 18;[EPub Ahead of Print], TJ Tan, S Sammons, YH Im, L She, K Mundy, R Bigelow, TA Traina, C Anders, J Yeong, E Renzulli, SB Kim, R DentFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.